isoxazoles has been researched along with pifithrin mu in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benítez, S; Cabiscol, E; Dolcet, X; Domingo, M; Maiques, O; Marti, RM; Martinez, M; Matias-Guiu, X; Ribera, J; Santacana, M; Valls, J; Vea, A; Vilella, R; Yeramian, A | 1 |
1 other study(ies) available for isoxazoles and pifithrin mu
Article | Year |
---|---|
2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels.
Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Glutathione; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Isoxazoles; MAP Kinase Signaling System; Melanoma; Mice, SCID; Neoplasm Metastasis; NF-kappa B; Oxidation-Reduction; Oxidative Stress; Resorcinols; RNA, Messenger; Skin; Sulfonamides; Xenograft Model Antitumor Assays | 2016 |